Financial Ratio Analysis on Beximco Pharma

BEXIMCO Pharmaceuticals

Projected Amount and Ratios for 2013,2014,2015,2016

Project Cost | | | Sources of Finance | |

Particulars | Taka | | Equity | 18,408,161,859 |

Land and land development | 3,302,101,973 | | Project Loan | 6,181,648,733 |

Building and other civil Works | 5,449,755,930 | |   |   |

Plant & Machinery | 4,627,921,371 | | Debt/ Equity Ratio | 1/3 |

Furniture | 97,859,648 | |

Office Equipment | 108,248,009 | |

Transportation | 273,680,514 | |

Contingency | 2,342,290,771 | |

Current Asset and Others | 8,387,952,376.00 | |

Total Cost | 24,589,810,592 | |

Projected Sales Revenue, COGS and Operating cost |

  | Unit | 2012 | 2013 | 2014 | 2015 | 2016 |

Sales in value- Total | Taka | 9,289,115,284 | 10,682,482,576.60 | 12,284,854,963.09 | 14,127,583,207.55 | 16,246,720,688.69 |

Cost of goods sold- Total | Taka | 4,899,713,857 | 5,634,670,936 | 6,479,871,576 | 7,451,852,312 | 8,569,630,159 |

COGS to Sales |   | 0.53 | 0.53 | 0.53 | 0.53 | 0.53 |

Operating Expenses |   |   |   |   |   |   |

Selling, Marketing and Distribution |   | 1849296520.00 | 2034226172.00 | 2237648789.20 | 2461413668.12 | 2707555034.93 |

Administartion |   | 332225347.00 | 365447881.70 | 401992669.87 | 442191936.86 | 486411130.54 |

Total opearting cost to sales |   | 2181521867.00 | 2399674053.70 | 2639641459.07 | 2903605604.98 | 3193966165.47 |

  |   |   |   |   |   |   |

Total opearting cost | Taka |...